Aurora Cannabis (ACB) Free Cash Flow (2017 - 2025)
Aurora Cannabis (ACB) reported Free Cash Flow of -$19.2 million for Q1 2025, up 8.77% year-over-year from -$17.6 million in Q1 2024, and down 179.54% quarter-over-quarter from $24.1 million in Q4 2024.
Aurora Cannabis (ACB) Free Cash Flow (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Free Cash Flow data on file, last reported at -$19.2 million in Q1 2025.
- Free Cash Flow for Q1 2025 came in at -$19.2 million, up 8.77% year-over-year; the trailing twelve-month figure through Dec 2025 was -$19.2 million (down 1114.71% YoY), and the FY2025 annual result was -$455086.5, up 99.05% from the prior year.
- Free Cash Flow retreated to -$19.2 million in Q1 2025 per ACB's latest filing, from $24.1 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $24.1 million in Q4 2024 and troughed at -$61.4 million in Q2 2021.
- A 5-year average of -$18.6 million and a median of -$19.9 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2024: Free Cash Flow slumped 289.46% in 2021, then surged 1419.93% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$12.7 million in 2021, then plunged by 244.53% to -$43.6 million in 2022, then soared by 95.81% to -$1.8 million in 2023, then jumped by 1419.93% to $24.1 million in 2024, then slumped by 179.54% to -$19.2 million in 2025.
- Business Quant data shows ACB's Free Cash Flow at -$19.2 million in Q1 2025, $24.1 million in Q4 2024, and -$14.9 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 46.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -19.19 Mn |
| Mar 31, 2025 | -19.19 Mn |
| Dec 31, 2024 | 24.12 Mn |
| Dec 31, 2024 | 24.12 Mn |
| Sep 30, 2024 | -14.92 Mn |
| Sep 30, 2024 | -14.92 Mn |
| Jun 30, 2024 | 10.25 Mn |
| Jun 30, 2024 | 10.25 Mn |
| Mar 31, 2024 | -21.03 Mn |
| Mar 31, 2024 | -21.03 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Sep 30, 2023 | -19.91 Mn |
| Sep 30, 2023 | -19.91 Mn |
| Dec 31, 2022 | -43.59 Mn |
| Dec 31, 2022 | -43.59 Mn |
| Sep 30, 2022 | -20.44 Mn |
| Sep 30, 2022 | -20.44 Mn |
| Jun 30, 2022 | -16.27 Mn |
| Jun 30, 2022 | -16.27 Mn |